Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office
PremiumPress ReleasesMedigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office
2M ago
Medigene’s Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
PremiumPress Releases
Medigene’s Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
2M ago
Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
PremiumPress Releases
Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
2M ago
Medigene AG reports Financial Results and  Business Update for Q1 2024
PremiumPress ReleasesMedigene AG reports Financial Results and Business Update for Q1 2024
3M ago
Medigene presents streamlined 6-day, high stemness  TCR-T therapy production process
PremiumPress Releases
Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
3M ago
Medigene to Present at Upcoming Scientific Conferences
PremiumPress Releases
Medigene to Present at Upcoming Scientific Conferences
3M ago
Medigene AG to report full year 2023 financial results  on March 28, 2024
PremiumPress ReleasesMedigene AG to report full year 2023 financial results on March 28, 2024
4M ago
Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual Meeting
PremiumPress Releases
Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual Meeting
5M ago
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo
PremiumPress Releases
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100